| Views | |
|---|---|
| The dual combination therapy panobinostat-lorlatinib is effective against neuroblastomas harboring genomic TERT rearrangements and ALK mutations | 153 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| The dual combination therapy panobinostat-lorlatinib is effective against neuroblastomas harboring genomic TERT rearrangements and ALK mutations | 0 | 23 | 27 | 35 | 30 | 17 | 21 |
| Views | |
|---|---|
| dissertation_linke.rb.pdf | 134 |
